Kenneth Dipietro's Net Worth
$7.02 Million
Who is Kenneth Dipietro?
Kenneth Dipietro has an estimated net worth of $7.02 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., Cerevel Therapeutics Holdings, Inc., and INVIVO THERAPEUTICS HOLDINGS CORP..
SEC CIK
Kenneth Dipietro's CIK is 0001540188
Past Insider Trading and Trends
2015 was Kenneth Dipietro's most active year for acquiring shares with 6 total transactions. Kenneth Dipietro's most active month to acquire stocks was the month of January. 2017 was Kenneth Dipietro's most active year for disposing of shares, totalling 12 transactions. Kenneth Dipietro's most active month to dispose stocks was the month of January. 2016 saw Kenneth Dipietro paying a total of $674,327.70 for 16,784 shares, this is the most they've acquired in one year. In 2015 Kenneth Dipietro cashed out on 13,424 shares for a total of $2,449,373.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
EVP Human Resources
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +82.30% | 3.24K |
$278.66 | -$684,399.16 | 7.18K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +9.33% | 336 |
$258.99 | -$77,697.00 | 3.94K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +117.71% | 1.95K |
$247.22 | -$338,444.18 | 3.6K |
Feb 12
| |||
Form 4/A
|
∞
| 2.47K |
—
|
—
| 2.47K |
Feb 1
| |||
Form 4
|
∞
| 1.65K |
$273.45 | $452,286.30 | 1.65K |
Feb 1
| |||
Form 4
| -100.00% | -803.00 |
$415.46 | -$333,614.38 |
0
|
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -59.67% | -1.19K |
$389.11 | -$462,262.68 | 803 |
Scheduled
|
Feb 17
| ||
Form 4
|
∞
| 1.99K |
$392.11 | -$695,211.03 | 1.99K |
Feb 12
| |||
Form 4
| -100.00% | -1.66K |
$389.03 | -$644,233.68 |
0
|
Scheduled
|
Feb 2
| ||
Form 4
|
∞
| 1.66K |
$389.16 | -$314,052.12 | 1.66K |
Feb 1
| |||
Form 4
|
—
|
0
|
$319.46 | -$717,511.14 |
0
|
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
| -100.00% | -1.66K |
$299.01 | -$494,861.55 |
0
|
Scheduled
|
Feb 4
| ||
Form 4
|
∞
| 1.66K |
$312.64 | -$252,613.12 | 1.66K |
Feb 1
| |||
Form 4
| -100.00% | -1.44K |
$242.00 | -$348,480.00 |
0
|
Scheduled
|
Sep 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
∞
| 1.44K |
$157.30 | -$111,840.30 | 1.44K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cerevel Therapeutics Holdings, Inc. (CERE) No price found
Chief Human Resources Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
$22.48 | -$303,608.00 | 24.66K |
Dec 22
| |||
Form 4
| +45.03% | 7.66K |
$41.42 | -$259,143.54 | 24.66K |
Dec 19 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |